BioVaxys Technology Corp. (BIOV.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.4 Million CAD | 41.14% |
| 2022 | -4.08 Million CAD | 36.41% |
| 2021 | -6.41 Million CAD | -486.69% |
| 2020 | -1.09 Million CAD | -376.29% |
| 2019 | -229.69 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -370.7 Thousand CAD | 91.16% |
| 2024 Q3 | -802.18 Thousand CAD | -48.78% |
| 2024 Q2 | -539.19 Thousand CAD | -45.45% |
| 2023 Q2 | 97.97 Thousand CAD | 112.46% |
| 2023 Q1 | -786.03 Thousand CAD | 14.93% |
| 2023 FY | -6.45 Million CAD | -58.1% |
| 2023 Q4 | -4.19 Million CAD | -1022.91% |
| 2023 Q3 | 454.33 Thousand CAD | 363.75% |
| 2022 Q1 | -1.2 Million CAD | 51.95% |
| 2022 Q4 | -923.95 Thousand CAD | -1.6% |
| 2022 FY | -4.08 Million CAD | 36.41% |
| 2022 Q3 | -909.43 Thousand CAD | 12.55% |
| 2022 Q2 | -1.04 Million CAD | 13.93% |
| 2021 Q4 | -2.51 Million CAD | -181.52% |
| 2021 FY | -6.41 Million CAD | -486.69% |
| 2021 Q1 | -1.53 Million CAD | -91.76% |
| 2021 Q3 | -893.39 Thousand CAD | 40.27% |
| 2021 Q2 | -1.49 Million CAD | 2.75% |
| 2020 Q2 | -65.41 Thousand CAD | -94.64% |
| 2020 Q1 | -33.6 Thousand CAD | 50.49% |
| 2020 FY | -1.09 Million CAD | -376.29% |
| 2020 Q4 | -802.03 Thousand CAD | -306.44% |
| 2020 Q3 | -197.33 Thousand CAD | -201.65% |
| 2019 Q3 | -37.81 Thousand CAD | 35.65% |
| 2019 Q1 | -65.44 Thousand CAD | 49.77% |
| 2019 Q4 | -67.88 Thousand CAD | -79.53% |
| 2019 Q2 | -58.76 Thousand CAD | 10.21% |
| 2019 FY | -229.69 Thousand CAD | 0.0% |
| 2018 Q4 | -130.28 Thousand CAD | -320.33% |
| 2018 Q3 | -30.99 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 52.121% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 68.883% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 25.851% |
| ChitogenX Inc. | -2.83 Million CAD | 15.102% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 35.738% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 81.016% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | -665.179% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 52.759% |
| Glow Lifetech Corp. | -1.64 Million CAD | -46.258% |
| Lexston Life Sciences Corp. | -674.71 Thousand CAD | -256.09% |
| Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | -214.909% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | -536.227% |
| MYND Life Sciences Inc. | -1.8 Million CAD | -32.904% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -99.834% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 21.073% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | -149.459% |
| Telescope Innovations Corp. | -5.76 Million CAD | 58.337% |